ArticleColombia medica (Cali, Colombia)2018
Cancer incidence and mortality in Bucaramanga, Colombia. 2008-2012.
Article in Colombia medica (Cali, Colombia), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Multitarget Design of Steroidal Inhibitors Against Hormone-Dependent Breast Cancer: An Integrated In Silico Approach.International journal of molecular sciences · 2025Article
- Article
- Article
- Frequency of hematologic malignancies in the population of Arica, Chile.Oncology letters · 2019Article
- Epidemiology of cancer in Colombia.Colombia medica (Cali, Colombia) · 2018Article
- Cancer incidence and mortality in Medellin-Colombia, 2010-2014.Colombia medica (Cali, Colombia) · 2018Article
- Reliable information for cancer control in Cali, Colombia.Colombia medica (Cali, Colombia) · 2018Article
- Cancer incidence and mortality in the Metropolitan Area of Bucaramanga, Colombia, 2013-2017.Colombia medica (Cali, Colombia)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCancer is a burden in the world, especially for the least developed countries. The Population Registries of Cancer are fundamental in order to know the territorial profiles of cancer, and to evaluate the impact of their control programs.
objectiveTo estimate the incidence and mortality from cancer in the Metropolitan Area of Bucaramanga in the period 2008-2012.
methodsA descriptive population study of cancer incidence and mortality in the Metropolitan Area of Bucaramanga was conducted. Primary invasive cancer cases from the 2008-2012 period was obtained from the RPC-AMB base. Population and death data were provided by the National Administrative Department of Statistics (DANE, for its initials in Spanish). Crude rates of global and specific incidence and mortality were estimated by sex, and standardized incidence and mortality rates.
resultsDuring the five-year period, 8,775 incidents of cancer were recorded (excluding non-melanoma skin cancer). The global standardized incidence rates per 100,000 person-years were 151.7 in men and 157.2 in women. The main locations were prostate, stomach and colorectal, in men; breast, thyroid and colorectal in women. The standardized mortality rate per 100,000 person-years was 94.8 in men and 78.0 in women.
conclusionThe incidence and mortality rates in most locations are lower than the national ones and those in the previous quinquennium in the Metropolitan Area of Bucaramanga. Thyroid cancer, colorectal cancer, and leukemia show a tendency to increase, which demands further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.